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Since the concept of the immune system based upon a network of B cells was first 
proposed, our understanding of immunoglobulin gene expression and cell interaction 
has expanded  to a  remarkable degree (1). Jerne's original hypothesis has since been 
extended to take into account these recent developments, particularly in the area of 
expression of idiotypes by T  cells and T  cell-derived factors (2, 3). It has been shown 
quite  convincingly that  specific T  cells bear idiotypic determinants  which  interact 
with anti-idiotypic antisera raised against the major idiotypes expressed in the serum 
of immunized animals (4,  5).  Idiotypic as well as anti-idiotypic T  lymphocytes have 
been shown to play a dominant role in regulating the expression of specific idiotypes 
during normal immune responses (6). 
In  general,  idiotypic  interactions  have so  far dealt  only with  responses  towards 
individual epitopes, whereas in classic immunology, immune responses are primarily 
based  upon  a  cooperative  association  between  clones  of lymphocytes  specific  for 
different epitopes of a complex antigen molecule. Clearly, if idiotypic regulation can 
so markedly control immune responses towards a given epitope, then it is conceivable 
that the effects may also influence the outcome of responses towards other idiotypically 
unrelated  determinants on the same molecule. It would seem unlikely that idiotypic 
regulation operates in isolation of regulation based upon hapten-carrier interactions. 
Predictable as this hypothesis may be, it has not  been verified in any experimental 
system to date. 
In our laboratory, the molecular basis of the immune response to ferredoxin  (Fd) 1 
has  been  studied.  Ferredoxin  is  a  simple  antigen  that  consists  of 55  amino  acid 
residues.  It  was  found  to  have  only  two  antigenic  determinants,  one  of which  is 
located  within  a  seven-amino acid  portion  of the  NH2-terminal  of the  protein  (N 
epitope), and the other which consists of the five amino acids located at the COOH- 
terminal  (C  epitope)  (7).  The existence of these  two determinants  of Fd  has  more 
1  Abbreviations used in th~s paper: CFA, complete Freund's adjuvant; DME, Dulbecco's modified Eagle's 
medium; ELISA,  enzyme-linked  immunosorbem  assay; Fd, ferredoxin; KLH, keyhole limpet hemocyanin; 
MHC, major h~stocompatibility complex; NRS, normal rabbit serum; PBS, phosphate-buffered saline; 
PC, phosphory|choline. 
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recently  been  defined  through  the  isolation  of  hybridomas  secreting  monoclonal 
antibodies with specificities for either epitope (8).  In mice, it has been shown that the 
immune response  to  Fd  is  under strict  major  histocompatibility complex  (MHC) 
contro| (9). In view of the fact that each Fd molecule possesses only a  single copy of 
each epitope, the restriction of an immune response to these two non-cross-reacting 
determinants provides a useful experimental model with which to investigate theories 
of immune regulation. 
Recently, the idiotype of one monoclonal anti-Fd antibody has been shown (10)  to 
be  representative of a  significant proportion  of IgG  antibodies in  serum  that  are 
directed towards the N epitope. In this publication, we show that whereas this idiotype 
constitutes a  small fraction of the total anti-Fd antibody, idiotypic interactions that 
regulate its expression also exert  significant influence over the response towards the 
other, C  epitope. 
Materials and Methods 
Details concerning the purification of Fd, derivation of the monoclonal anti-Fd antibody, 
Fd-1, enzyme-linked immunosorbent assay  (ELISA) of anti Fd antibody in immune serum, 
and the preparation and characterization of anti-idiotype serum have been given in a previous 
publication (10). 
Animals.  Female mice 6-8 wk of age of the  following strains were  purchased  from The 
Jackson Laboratory, Bar Harbor, ME: B 10.BR/oSn, DBA/2J, C3H/J, CBA/J, SjL/J, AKR/ 
J, SM/J, and C58/J. They were used between the ages of 10 and 20 wk. 
Antigens and Immunization.  Mice  we~ze immunized with  50  #g  purified  Fd  emulsified in 
complete Freund's adjuvant (Difco Laki'oratories, Detroit, MI) by intraperitoneat injection on 
day 0.  Primary immune sera were  obtained on day 21  by retro-orbital bleeding. Secondary 
immunization  with Fd was given on day 28 by intraperitoneal injection of 50/Lg Fd emulsified 
in  incomplete Freund's adjuvant  (Difco  Laboratories),  and  secondary  immune sera  were 
subsequently taken on days 35 and 49. 
Radioimmunoassay for Idiotype.  Idiotype expression in mouse serum was  measured using a 
solid-phase  ELISA  inhibition (10) or  a  radioimmunoassay. Affinity  isolated  antiidiotype 
antibody was used to coat the wells of a vinyl 96-weU microtest plate (Microtiter; Dynatech 
Laboratories, Alexandria, VA) at a concentration of 1 /xg/ml in pH 9.6 carbonate buffer for a 
period of 1 h at 37°C. Subsequently, coated plates were washed with phosphate-buffered saline 
(PBS) -Tween buffer and incubated for 15 rain with PBS-Tween buffer containing  0.1% bovine 
serum albumin (S/gma Chemical Co., St.  Lou/s, MO)  and normal BI0.BR serum  (0.25%). 
Plates were  then washed  in PBS-Tween buffer before  incubation with assay  samples. Test 
samples of immune sera at  a  dilution of  1:40 in PBS-Tween buffer and control samples of 
nonimmune  sera containing  added quantities of monoclonals Fd-1 antibody ranging from 1 to 
1,280 ng/ml were dispensed in triplicate to the wells of prepared plates. After 60 min incubation 
at room temperature, the plates were  washed and incubated as before with  100/~l/well of a 
solution of 125I-labeled Fd-1 monoclonal antibody labeled by the chloramine T procedure (11) 
using a total of I50,000 cpm/well (sp act 2.4 X 109 cpm/mg protein). After 60 min, the plates 
were washed, the individual wells were cut out, and the amount of radioactivity bound per well 
was counted in a Beckman Biogamma radioisotope counter (Beckman Instruments, Fullerton, 
CA)~ A standard inhibition curve was constructed from counts obtained from samples contain- 
ing normal  B10.BR  serum  and  known  amounts of cold  Fd-]  monoclonal antibody as  a 
competitor. Percent inhibition was  calculated using cpm per we~l ia the presence of normal 
mouse serum as zero, and taking counts per minute in the lower plate portion of the curve as 
100% inhibition. Percent inhibition  of binding in the presence of test sera was then read directly 
from this standard curve. Values obtained were corrected for dilution and are expressed  as ng 
equivalents of idiotype per ml of serum. The lower limit of sensitivity for this assay  depends 
upon the detection limit of the standard curve (-1 ng/ml of idiotype), and the working dilution 
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(40 ng/ml of serum) as well as the range of variation observed between serum samples taken 
from nonimmune individuals establishes a statistical baseline of 50 ng/ml. 
Adoptive  Transfer of Anti-ldiotype-treated Spleen Cells.  Spleen  cells  from  either  immune  or 
nonimmune B10.BR  mice were resuspended in anti-idiotype serum at a  concentration of 12 
#g  equivalents/ml,  or in  an  equal  dilution of normal  rabbit  serum  (NRS)  that  had  been 
adsorbed with mouse immunoglobulin for a  period of 45 min on ice. Cells were then washed 
three  times with  Dulbeeco's modified Eagle's medium  (DME)  (Gibeo Laboratories, Grand 
Island Biological Co., Grand Island, NY) and then resuspended in rabbit complement (Low- 
tox, Cedarlane Laboratories, Ontario, Canada) at a final dilution of 1:5 in DME and incubated 
45 rain at 37°C. In later experiments, the complement step was not carried out. Cells were then 
washed  three times in  DME, adjusted to a  concentration of 2  ×  l0  s cells/ml, and injected 
intraperitonealty (0.1  ml/mouse) into normal B 10.BR  mice that had received 500 rad whole- 
body irradiation from a gamma source (Gammacell 200;  Atomic Energy of Canada, Ottawa, 
Canada)  24  h  previously.  Immediately  after  cell  transfer,  recipient  mice  were  given  an 
intraperitoneal injection of 50/~g Fd in complete Freund's adjuvant. Antibody titers of animals 
receiving nonimmune cells were determined from sera taken 21  d post-transfer, whereas titers 
of transferred immune spleen cells were determined from sera taken 7 or 21 d post-transfer. In 
some experiments, spleen ceils were first fractionated before treatment  with anti-idiotype or 
NRS using the techniques of nylon wool separation  (12)  for T  cells and  pretreatment with 
monoclonal anti-Thy-1.2 plus complement for B cell enrichment. Nylon wool-treated cells were 
shown to be mainly T cells, in that 98% of them were killed with anti-Thy- 1 plus complement. 
Cell recovery was between 20 and 30%. Cell recovery in anti-Thy-1 plus complement-treated 
spleen cells was between 40 and 50%. After anti-idiotype  plus complement treatment, equivalent 
numbers of T and B cells were resuspended to a concentration of 2 ×  108 cells/ml for injection 
into irradiated recipients. 
Epitope Specificity and Quantification of Antisera.  The amount of anti-Fd antibody in immune 
sera was determined by a  quantitative ELISA procedure that  has been described previously 
(9).  Briefly, affinity-isolated anti-Fd antibody was labeled with  x~sI, and the specific activity 
determined. The antibody was then used in a standard ELISA. After the plates had been read, 
they were rinsed, individual wells were cut out, and the counts per minute were determined in 
a gamma counter. A standard curve was established from which the amount of  specific antibody 
in subsequent ELISA could be calculated. 
The procedure by which the relative amounts of antibody in antisera directed to either the 
N  or C  epitope of Fd was calculated has also been described in detail previously (8).  Briefly, 
preparations of Fd  were  selectively degraded  with  either  trypsin  (which  inactivates the  N 
epitope by cleavage of lys at  the third position) or carboxypeptidase A  (which removes the 
terminal gln-glu of Fd and inactivates the C  epitope). Antisera were assayed in ELISA with 
whole Fd and both fragments. Relative color development with the fragments is a function of 
antibody directed to either the N or C epitope and can be quantified in this way. 
Results 
The amino acid sequence of Fd, showing the location of its two antigenic determi- 
nants,  is  shown  in  Fig.  1.  In  high  responder  mice  (H-2k),  antibody  titers,  after 
secondary antigen stimulus, reach  --20.0 #g/ml.  This moderate level of immunoge- 
nicity, even  in high responder mice, is not surprising considering the low molecular 
weight of Fd, and that the response is generated through only two epitopes. In other 
systems, anti-hapten antibody titers up to 5 mg/ml have been obtained, however, this 
response occurs after immunization with hapten coupled to muhi-determinant carriers 
(13-14).  Production  of such  large  quantities  of antibody  presumably  reflects  the 
magnitude  of T  cell help  provided by the carrier.  In  comparison,  Fd is a  molecule 
that can be viewed as two covalently linked haptenic groups. Thus, there can be only 
a single carrier moiety providing help for the alternate hapten. Because of the relative 
simplicity of this immunogen,  it was believed that  Fd could provide a  model system 288  IDIOTYPIC MARKERS  ON  REGULATORY T  CELLS 
Trypsin 
1 
H~N-Ala-Tyr-  Lys-Ile-Ala-Asp-Ser-Cys-Val-Ser-Cys-Gly-Ala-Cys-Ala-Ser-Ala-Cys-Pro-Val-  Asn 
1  2l 
Ala-  lie- Ser-Gln-Gly-Asp-  Ser-Ile- Phe-Val-lie-Asp-Ata- Asp 
22  35 
Thr-Cys-Ile-Asp-Cys-Gly-Asn-Cys-Ala-Asn-Val-Cys-Pro-Val  -Gly-Ala-Pro-Val-Gln-Glu-COOH 
36  l  55 
Carboxypeptidase A 
FIG.  1.  The amino acid sequence of .Fd. The two major epitopes (N and C) are designated, as are 
the two points at which selective enzyme degradation (trypsin or carboxypeptidase A) inactivates 
the immunologic properties of either epitope. 
whereby  idiotypic regulation  could be examined  in  the  context  of a  hapten-carrier 
relationship. 
The approach used in this study was to generate monoclonal antibody directed to 
one of the two epitopes on Fd (the N  epitope in this instance), identify a  monoclonal 
antibody representing  a  conserved idiotype in  anti-Fd  antibody raised  in syngeneic 
mice, develop anti-idiotypic antisera to the monoclonal antibody, and test  its ability 
to influence the response of Fd immune spleen cells to either the N  or C  epitope using 
an adoptive transfer system. 
The  monoclonal  antibody  used  in  this  study  has  been  described  previously  (10), 
and is designated as Fd-1. Briefly, Fd-1 is an IgG2u immunoglobulin that has binding 
specificity for the N  epitope of Fd. An anti-idiotypic serum to Fd-1  (anti-Fd-1), raised 
in  rabbits,  has  also  been  described  previously  (10).  It  was  shown  to  be  truly  anti- 
idiotypic after appropriate absorptions by its ability to competitively inhibit binding 
of  Fd  to  Fd-1.  In  addition,  affinity-purified  rabbit  anti-Fd-1,  when  used  as  an 
immunoadsorbent,  was capable of binding serum  anti-Fd  antibody in which it  was 
shown that >90% of such idiotypically selected antibody demonstrated strict binding 
specificity for the N  epitope  (10). 
This  anti-idiotypic  antibody  was  used  in  a  solid-phase  radioimmunoassay  to 
determine  the  frequency of expression  of the  Fd-1  idiotype  in  Fd-immune  B10.BR 
and  other  strains  of mice.  A  standard  curve  for the binding  of 125I-labeled  Fd-1  to 
anti-Fd-1  (solid phase)  is shown  in  Fig.  2. The assay  for idiotype expression  in  Fd- 
immune sera was carried out by standard competitive inhibition of binding of labeled 
Fd-1  in the presence of I:4.0 dilutions of Fd-immune serum.  125I-|abeled monocIonal 
Fd-I  antibody was  added  to the  assay at  a  concentration  sufficient  to saturate  50- 
75% of binding sites on the solid phase. 
The results of this survey for idiotype expression in immune serum from a  number 
of different  mouse strains  is  shown in Table  I. The ratio  of N/C  serum  antibody  is 
characteristic  of each  strain,  and  constant  in  mice  of the  same  strain.  By  ELISA 
measurement,  ~80%  of the  antibody  produced  in  high  responder  animals  (H-2  k 
haplotype)  is shown to be directed  to the C-epitope.  Intermediate  responders  (H-2 b 
and H-2  ~ haplotype) make essentially equal amounts of antibody directed toward the 
N  and C  epitopes.  As can be seen  in Table I, expression  of the Fd-1  idiotype is not 
related  to  high  or  intermediate  responder  status,  but  appears  to  map  to  allotypes 
coding for genes linked to the IgH gene complex and is observed in mice bearing the 
Ig-1  b allotype. A  closer examination of this linkage is hampered by the fact  that  the M.  WEAVER,  R.  SINGHAI,  L.  SIKORA,  AND J.  G.  LEVY 
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FIG.  2.  Standard curve showing the cold inhibition of binding of 125I-labeled Fd- l  to plates coated 
with affinity purified anti-Fd-1. Inhibition was carried out in  1:40 normal B10.BR serum to which 
varying concentrations of Fd- 1 had been added. 
TABLE  I 
Analysis of Anti-Fd Sera Taken from Mice of Various Haplotypes and Allotypes after Secondary 
Immunization  with Fd 
Percent 
Strain  Haplo-  Allotype  Anti-Fd  Anti-N*  Idiotype~  idiotype 
type  expression  expression 
~g/rnl ± SEM  ng/rnl +_ SEM 
B10.BR  k  b  9.03 ±  .85  1.81 ±  0.42  310 +  37  22.9 
B 10.S  s  b  1,20§  0.66  88  13.3 
C57BL/6  b  b  10.51 ±  1.25  2.21  ±  0.56  237 ±  77  10.8 
SJL  s  b  1.35 +  0.15  0.74 +  0.23  250 +  64  36.8 
CE/J  k  f  13.99 +  0.32  1.24 ±  0.20  <40  -- 
AKR/J  k  d  10.77 ±  0.159  1.15 +  0.16  <40  -- 
ST/J  k  a  12.32 +  0.76  2.38 zt: 0.24  <40  -- 
RF/J  k  e  10.66 +  0.139  0.51  +  0.22  <40  -- 
C58/J  k  a  13.2 +  0.42  1. I 1 ±  0.29  <40  -- 
All animals were bled 7 d after receiving antigen. 
* Antibody directed to the N epitope as calculated in the ELISA. 
:~ Antibody expressing the Fd- l  idiotype as calculated by solid-phase radioimmunoassay. 
§ Between 8 and  15 mice were used in each group, with the exception of B10.S sera, in which a  pool of 
antiserum was used. 
appropriate allotype recombinant strains are derived from the H-2  d background, a 
haplotype which designates unresponsiveness to Fd (9). 
Although a wide variation in expression of the Fd-1 idiotype in responder B10.BR 
mice was observed (between 0 and  100% of the total anti-N antibody produced), the 
median  level of expression  of this  idiotype was  310  ng/ml  (~20%  of the  total  N 
epitope-specific antibody  in  immune  serum).  It  was  therefore recognized  that  the 
monoclonal Fd-1 antibody represented a major idiotype in B 10.BR anti-Fd serum, as 290  IDIOTYPIC  MARKERS  ON  REGULATORY  T  CELLS 
it does in other mice of the IgH allotype,  and one that is conserved  during a  secondary 
response. 
A  number  of adoptive  transfer experiments  were carried  out  to determine  whether 
the  anti-Fd-1  serum  would  have  any  effects  on  the  adoptive  primary  or  secondary 
response  to  Fd  in  B10.BR  mice.  Splenocytes  from  nai've  or  Fd-primed  B10.BR  mice 
were treated in vitro with the anti-idiotypic  serum with or without  complement  before 
EXPERIMENT  TREATMENT  ANTIGEN 
NRS  +  C  Fd 
2 
ANTI- F(I-I+C  Fd 
NRS +  C  Fd 
KLH 
ANTI-Fd - I +C  Fd 
KLH 
ANTI- Fd-I  Fd 
KLH 
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Fro.  3.  Anti-Fd responses  in the adoptive secondary response to Fd in B10.BR mice. Experiment 
2;  the anti-Fd  response after the adoptive transfer  of Fd-immune  splenocytes treated with either 
anti-Fd-1 or NRS plus complement. Test bleeds were carried out 7 d after cell transfer.  Experiment 
4; adoptive transfer of Fd-primed splenocytes treated with either NRS or anti-Fd- 1 plus complement 
or anti-Fd-I  alone.  Recipient  animals were  immunized  simultaneously with  Fd  and  KLH.  Test 
bleeds were done 21 d after adoptive transfer. 
TABLE  II 
Influence of Anti-Fd-I on the Adoptive Primary or Secondary Response of B IO.BR Mice to Fd 
Percent 
Experiment  Treatment  Time of bleed  Anti-Fd  P* anti-N  Anti-N  ldiotype  P*  idiotype 
number  expression 
expression 
ILg/ml ± SEM  ~g/ral  ± SEM  ng/ml ± SEM 
Primary 
1:~  NRS +  C§  21 d  1,82 +  0.95 
anti-Fd-I  +  C  21 d  3.89 ±  1.83  NS 
Secondary 
2~  NRS +  C  7 d  1.01 ±  0.57 
anti-Fd-1 +  C  7 d  2.94 ±  1.34  NS 
Secondary 
3[[  NRS +  C  7 d  1.07 ±  0.53 
anti-Fd-1 +  C  7 d  2.12 ±  0.9  <0.05 
anti-Fd+ 1  7 d  2.90 ±  0.95  <0.05 
Secondary 
411  NRS +  C  21 d  3.19 ±  1.92  <0.025 
anti-Fd-1  +  C  21 d  1327 ±  4.38  <0.05 
anti-Fd-I  21 d  1134 ±  4.77 
7.28 ±  1/.249  60.0 ±  32  8.3 
1.489 +  0.746  121.0 ±  57  N8  81 
0.239-*-0.212  87.2±41  39.8 
0.644 ±  0.340  358.4 ±  297  NS  56.5 
0.355 +  0.333  ND¶ 
0.560 ±  0.286  ND 
0.830 ±  0.444  ND 
+  0.974 +  070  340 ±  192  17.4'* 
4.240 zk 0.140  870 ±  476  NS  16.4 
2.280 ±  0.85  380 ±  144  NS  14.3 
Spleen cells from Fd-immune  or naive BI0.BR were treated with NRS +  complement or anti-Fd-1  zk complement before injection into irradiated 
BI0.BR recipients and bled either 7 or 21 d  later. Each experient bad 6  (experiments i  and 2) or  i0 (experiments 3 and 4) animals per group. 
• Differences  m  titers between  anti-Fd-i-treated  mice and  NRS-trcated controls  were analyzed by Student's  t  test  to estabtish  the signi/]cance of 
differences  between the groups.  NS, not  significant (P ~  0,05), 
:~ Six animals per experimental group. 
§ Complenmnt 
U I0 animals pcl experimental group 
¶ Not determined 
** Percentages ale based on  values  obtained only from  sera of mice which  had detectable levels of N epitope-spccific  antibodies and thezeforc  do not 
reflect  a direct percentage of number~  shown  in columns 6 and 7. M.  WEAVER, R.  SINGHAI, L.  SIKORA, AND J.  G.  LEVY  291 
injection into irradiated B 10.BR recipients, which were simultaneously boosted with 
Fd and keyhole limpet hemocyanin (KLH) and bled  7 and/or 21  d later.  Sera were 
tested  for their reactivity to Fd, KLH, the N  and (3 epitopes, and expression of the 
Fd-1 idiotype. Results of several experiments are shown in Fig. 3 and Table II. It can 
be seen  that  treatment  of Fd-immune splenocytes of anti-Fd-1  anti-idiotype before 
adoptive transfer results in an overall increase in anti-Fd-specific antibody in adop- 
tively transferred mice, regardless of the immune status of the transferred cells.  The 
effect is apparent whether or not cells are treated with complement in the presence of 
anti-idiotype. The effect is most pronounced 3 wk after cell transfer in the adoptive 
secondary response. 
The specificity of this effect was established by the observation that the response to 
KLH did not differ significantly between the three experimental groups (Fig.  3).  In 
other experiments  (data not shown) it was also observed that the adoptive secondary 
response to KLH in B10.BR mice was not affected by treatment of transferred cells 
with either NRS or anti-Fd-1. A summary of various experiments of this nature are 
shown in Table II. In experiment  1, unprimed cells were treated with either anti-Fd- 
1 or NRS, adoptively transferred to irradiated  B10.BR mice, and primed with  Fd. 
Test bleeds taken at day 21 showed that sera from the two groups differed (but not 
significantly) in their titers to Fd in that animals receiving cells  pretreated with anti- 
Fd-1 appeared to be producing somewhat more antibody to Fd. When the nature of 
the  antibody was  analyzed  further,  it  was  found  that  the  ratio  directed  to  the  N 
epitope or the percent of the Fd- 1 idiotype expressed did not differ between the two 
groups. However, because the actual antibody titer was approximately doubled in the 
experimental  group, one saw a  doubling in  both  the amount of N  epitope-specific 
antibody  and  in  Fd-1  idiotype  expression.  In  the  adoptive  secondary Fd  response 
(experiments 2, 3, and 4), similar results are observed. When larger groups of animals 
were used the differences between NRS- and anti-Fd-l-treated groups were found to 
be significant.  In all experiments  done, anti-Fd-1  (_+ complement)  treatment  of Fd 
primed  spleen  cells  resulted  in  increased  anti-Fd  responses  in  recipient  animals. 
However,  whereas  levels  of both  N  epitope  specific  antibody  and  Fd-1  idiotype- 
positive  Ig were  both  increased  in  these  animals,  their  ratio,  in  comparison  with 
control  animals,  was  not  significantly  changed.  Two  clear  observations  were  thus 
made from these experiments:  the treatment of cells with anti-Fd-1  was influencing 
positively the total anti-Fd response (80% of which was still directed to the C epitope), 
and that this effect was not dependent on the presence of complement. 
Anti-idiotype treatment of adoptively transferred Fd-primed ceils did not appear 
to  be  eliminating  idiotype-positive  B  cells  as  unaltered  idiotype  expression  was 
observed in treated cells  and it  was therefore considered possible that the treatment 
was affecting a  T  cell  population.  Fd-immune splenocytes were  fractionated  using 
nylon wool or anti-Thy-l.2 plus complement. Enriched T  or B cell populations were 
treated with anti-Fd-1 or NRS before mixing and transfer to irradiated B 10.BR mice, 
which were tested for their adoptive secondary response to Fd. The results are shown 
in  Fig.  4.  In experiment  1,  it  can  be seen  that  only in  those animals  in  which  the 
transferred T  cells have been treated with anti-idiotype is the anticipated increase in 
the anti-Fd titer observed. In contrast, treatment of B cells  in this way has no effects 
on overall anti-Fd titer observed. In contrast, treatment of B cells  in this way has no 
effect on overall anti-Fd titers.  A second adoptive transfer of primed B 10.BR T  and 292  IDIOTYPIC MARKERS  ON  REGULATORY  T  CELLS 
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Fro.  4.  Anti-Fd responses in the adoptive secondary Fd response in B10.BR mice. Experiment  l: 
Fd-primed B10.BR  B or T  cell  enriched  populations were treated  with either anti-Fd-1  or NRS 
before mixing and transfer to irradiated  recipients. Animals were bled  7 d  after cell  transfer and 
antigenic stimulus. There were six  animals per group. Experiment 2:  Fd-primed T  cell  enriched 
populations were treated with anti-Fd-1  or NRS before mixing with equal number of Fd-primed B 
cell  enriched  populations and  transfer to  irradiated  recipients.  Recipients  were immunized with 
both Fd and KLH at the time of cell transfer and bled 21 d later. There were 12 animals per group. 
TABLE  III 
Influence of Anti-Fd-1  on the Adoptive  Secondary Response of BIO.BR Mice to Fd 
Treatment  Percent 
Exper-  Time  Fd- 1  idi- 
iment  Anti-N- 
of  Anti-Fd  P*  idiotype  otype 
num-  T  cells  B cells  bleed  epitope  expression  expres- 
ber  sion 
day  t~g/ml  +. SEM  I~g/ml +.  ng/ml +_ 
SEM  SEM 
NRS  NRS  7  1.22 +  0.88  ND:~ 
NRS  Anti-Fd-I  7  1.26 +  0.72  NS  ND 
Anti-Fd-1  NRS  7  3.05 +  2.83  NS  ND 
Anti-Fd-1  Anti-Fd-1  7  2.25 +  2.2  NS  ND 
NRS  7  1.4 +  0.55  ND 
Anti-Fd-I  7  2.8 ----- 0.8  NS  ND 
NRS  21  3.93 +  1.27  1.30 +_ 0.8  627 +_ 484 
Anti-Fd-1  21  23.63  +  12.0  <0.005  3.32 +-  1.1  555 +  264 
37.2 
16.7 
Spleen cells front Fd-primed B 10.BR mice were separated by nylon wool or anti-Thy-1 +  complement to 
yield  T  or B cell-enriched  populations. These populations were treated  with either  anti-Fd-I  or NRS 
before transfer into irradiated recipients. In experiment 2, recipients were immunized with both Fd and 
KLH. Animals were bled 7 and 21  d  later.  There were 6 animals per group in experiment 1 and  12 per 
group in experiment 2. 
* Differences in titers between anti-Fd  1-treated and NRS-treated and NRS-treated cells were analyzed by 
Students' t test  to establish significance of differences between groups. NS, not significant (P >  0.05). 
:~ Not done. 
B  cells were carried out. In this case, only T  cells were treated  with anti-Fd-1. Animals 
were  boosted  with  both  Fd  and  KLH.  The  21-d  response  data  are  shown  in  Fig.  4 
(experiment  2)  and  Table  III.  In  this  experiment,  as  in  the  whole  cell  treatment 
studies,  the  major  increase  in  antibody  titer  was  attributable  to  an  increase  in  C- M.  WEAVER,  R.  SINGHAI,  L.  SIKORA,  AND J.  G.  LEVY  293 
specific antibody, since the ratio of N/C specific antibody remains unchanged in anti- 
Fd-l-treated cells. Idiotype levels do not differ significantly between the two groups. 
That the effect is specific is demonstrated by the observation that the KLH response 
is not significantly different between the two treated groups. 
It would appear that anti-Fd-1 antiserum is capable of influencing a population of 
immunoregulatory T  cells, possibly suppressor cells, that bear the Fd-1  idiotype (are 
idiotype positive). The most profound increase in  antibody titers  as a  result  of this 
treatment is in antibodies directed to the C epitope, as they comprise 80% of the anti- 
ANTI-Fd-I  RI-I 
'~~  (hi  1©~ 
--=.@  , 
-4 bMdlne  N-bindN  N-binding  ©-_. ---© 
id 4-  NIlotypk:ally 
N-Mndlng  unrelated 
C-bhdlng 
Fla.  5.  Model for idiotypic interaction  in the immune response to Fd. A  major id  + regulatory T 
cell  (cell b) controls the level of help generated by other N-epitope binding T  cells (cell c), which 
may or may not  be  idiotypically  related  but control  the  level  of antibody  produced  by  B  cells 
reactive with the C-epitope. Elimination of this cell  (cell b)  by anti-Fd-I  increases the response to 
the C  epitope.  Because the responses to  the N  epitope  is also increased in this process, a  second, 
idiotype-negative regulatory T  cell  is also postulated (this population  [a]  would be bound by the 
Fd-1  monoclonal, because they are anti-idiotypic).  Elimination of either of these cell populations 
DAY  T  DAY O 
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Fd 
destroys this level of network regulation. 
TREATMENT 
pg ANTIBODY  PER ml 
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'  i 
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Anti-Fd response in B 10.BR mice treated before immunization with 10 #g Fd- 1 monoclonal 
antibody 7 d before immunization. Animals were bled 7 and 14 d after immunization, reimmunized 
on day 28, and bled again on day 35. In all instances, mice treated with Fd-1 alone showed no anti- 
Fd titer, and mice treated with Fd-1 and Fd had significantly higher titers ofanti-Fd antibody than 
did controls. There were  12 animals in each experimental group. 294  IDIOTYPIC MARKERS ON  REGULATORY T  CELLS 
TABLE  IV 
Influence  of the Monoclonal Fd-I on the Immune Response to Fd in BIO.BR Mice 
Day 7  Day 0 
Time 
Day  of  Anti-Fd or anti-  p.  Anti-N  Idiotype 
28  bleed  KLH  expression 
Percent 
idi- 
otype 
expres- 
SiO~'l 
day  t~g/m! +- SEM 
Fd-1  --  --  7 
Fd-I  Fd  --  7  1.646 ± 0.64  <005 
Fd-1  KLH  --  7  0.923  +_ 0.157§ 
--  Fd  --  7  0.485  +_ 0.259 
--  KLH  --  7  t.05  +_ 0.254{} 
Fd-1  0  --  14  0 
Fd-1  Fd  14  3,330  +  13  <0,005 
--  Fd  --  i4  0.500  ± 0.4 
Fd- 1  35  0 
Fd-1  Fd  Fd  35  27.18  +_ 7.98  <0.05 
--  Fd  Fd  35  11.38 + 4.63 
p.g/ml  + SEM  ng/ml +. SEM 
ND~:  182 -- 65 
0.338+0.87  112---53 
ND  133 +  64 
0.152 + 0.018  104+_61 
ND  0 
ND 
40 
10.450 +_ 3.78  386 __. 156  3.7 
5.300 +  2.20  2450 _.  1644  46.2 
* Differences between Fd-I treated immunized mice and untreated controls  were analysed by Students' t 
test to establish significant  differences between the two groups. 
:~ Not determined. 
§ Titers were calculated to KLH in these instances.  Differences are not significant  between the two groups. 
Fd  response.  It  is  of interest  to  note  that  neither  the  ratio  of N:C  epitope-specific 
antibody  nor  the  percent  of  idiotype  expression  is  altered  significantly.  It  was 
considered  possible  that  the  idiotype-positive T  immunoregulatory  cells have a  dual 
function:  regulation  of N-specific help,  and  regulation  of idiotype expression  by way 
of  an  anti-idiotypic  population  of,  presumably,  T  cells  (see  Fig.  5).  To  test  this 
possibility,  the effects of administration  of the monoclonal  Fd-1  antibody  (i.e., Ab-1) 
to nonimmune  B 10.BR mice was tested.  Mice were injected intraperitoneally with  10 
/lg of the monoclonal  Fd-1  7  d  before immunization  with  Fd.  The  results  are shown 
in  Fig.  6  and  Table  IV.  The  treatment  of mice  with  idiotype-positive  monoclonal 
antibody results in a  marked increase in the anti-Fd response to both epitopes;  the N/ 
C  ratio remains  constant,  thus,  a  large  net  increase  in  the response  to  the  C  epitope 
is  observed.  These  mice  were  reimmunized,  and  titers  of secondary  antibody  were 
measured.  The results  are shown  in Table  IV, in which  it can be seen  that  the trend 
is  essentially  the  same;  Fd-l-treated  animals  maintain  elevated  levels  of  anti-Fd 
antibody,  the  major  part  (70-80%)  of  which  is  directed  to  the  C  epitope.  The 
specificity of this effect was demonstrated  by the lack of significant difference between 
Fd-l-treated  or  untreated  KLH-immunized  animals  (Table  IV).  After  secondary 
immunization  it was noted that treatment of animals with the Fd-1 effectively reduced 
expression  of  the  Fd-1  idiotype  in  immune  serum.  Measurements  of  idiotype  in 
primary  serum  at  day  7  could  not  be  evaluated  in  terms  of the  response  to  Fd-1 
idiotype in  their serum  (Table  IV)  because  idiotype was  still detectable  (180  ng/ml) 
in  control  Fd-l-treated  animals.  However,  these  levels in  Fd-l-only  treated  animals 
dropped  to below detectable  levels after  14 d, indicating that  clearance of significant 
quantities  of the monoclonal had  occurred within this 21-d period. 
Discussion 
Idiotypic interactions  provide a  direct mechanism  by which T  and  B  lymphocytes 
sharing identical antigen specificity can communicate.  Considerable  evidence for the M.  WEAVER, R.  SINGHAI, L.  SIKORA, AND J. G. LEVY  295 
participation  of network interactions  in  the control  of immune responses has been 
described through  laboratory studies involving haptens  (13,  14),  polymeric antigens 
(15, 16), and proteins of defined structure (17-2t). In addition to these model systems, 
network  phenomena  have  also  been  implicated  as  pathologic  factors  in  state  of 
abnormal immune regulation  (22,  23).  Each of these examples, idiotypic in nature, 
are  therefore  consistent  with  the  central  principle  of  network  theory:  control  of 
immune  responses  through  idiotypic  interactions.  Equally  prominent  in  immune 
regulation,  however,  are  interactions  between  lymphocytes  of  differing  antigenic 
specificity (24). With respect to the average antigen molecule, one must propose either 
that T  and B  lymphocytes act  through  separate repertoires, or that  both modes of 
regulation  can  co-exist.  It  would  seem  reasonable  that  these  two  avenues  of cell 
interaction  might  be  integrated,  an  association  that  would  necessarily  show  some 
degree of functional  interdependence.  This prediction can be experimentally tested 
provided a very simple defined antigen molecule is available. 
We have described results of studies on a particular idiotype of the anti-Fd response 
in B10.BR mice. This choice of experimental antigen  is singular in several respects: 
because it is a  foreign bacterial protein obtained from a  soil anaerobe, it is therefore 
unlikely that  mice would  have been in  contact  with  this  antigen  through  environ- 
mental  exposure;  it  is  a  low  molecular  weight  antigen  consisting  of two  distinct 
epitopes separated by a  nonimmunogenic peptide spacer; responses to Fd are under 
strict immune response gene control; antibody responses to Fd are restricted in terms 
of both the magnitude and heterogeneity (9).  Because they are limited to these two 
epitopes, responses need not be analyzed under limiting immunization conditions nor 
conjugated with heterologous carriers to be made immunogenic. 
By  selecting  a  small  defined  protein  as  experimental  antigen  and  then  using  a 
monoclonal antibody, it has been possible to define a specific idiotype of the anti-Fd 
response  and  then  examine  its  relationship  to  the  overall  repertoire.  Because  this 
molecule contains only two antigenic determinants, and quantification of the response 
to  either  determinant  can  be  carried  out,  it  has  been  possible  to  account  for  the 
influence of anti-idiotypic antiserum on the anti-Fd  response at three levels: on the 
overall response, on the expression of the Fd-1 idiotype, and on the relative amounts 
of antibody formed directed to the N  or C  epitope in the molecule. 
The specific idiotype examined in this paper, Fd-I, is present as part of the normal 
repertoire of B 10.BR anti-Fd antibodies. B 10.BR mice (H-2  k) are high responders to 
Fd, as are all H-2  k strains, and this responsiveness maps to the I-A region of the MHC 
(9).  The Fd-1  idiotype is expressed in a  significant percentage of individual  B10.BR 
immune sera, and is also present in a number of other strains bearing the Ig-1  b allele 
of the heavy chain allotype linkage group (Table I). 
When  T  cells  or  whole  spleen  populations  were  treated  with  anti-idiotype  and 
transferred,  the  adoptive anti-Fd  response of recipients was uniformly higher  than 
that  of  control  animals.  These  results  imply  that  this  idiotype  is  expressed  on 
subpopulations  of T  cells,  which  possibly  play  a  regulatory  role  in  the  immune 
response. This increase in anti-Fd antibody was observed when either Fd-primed or 
unprimed ceils were treated with anti-Fd-1  +  complement. This implies that the Fd- 
1 idiotype is expressed not only on a population of Fd-primed regulatory (suppressor) 
cells,  but  also  on  a  population  of suppressor cells  present  representing  part  of the 
germ  line  repertoire.  These cells  may play a  significant  role  maintaining  a  steady 296  IDIOTYPIC MARKERS ON  REGULATORY T  CELLS 
state in the network. The existence of such regulatory T  cells has been demonstrated 
previously in a system involving the T-independent response to TNP and its regulation 
by a  population of T  cells exhibiting the MOPC 460 idiotype (25).  When sera from 
recipient animals were examined, it was observed that although there was an increase 
in the total amount of antibody to Fd, the N/C ratio was unchanged;  as 80% of the 
response is C  epitope directed,  any ratio-conservative increase will reflect a  large C- 
specific increase. On the basis of the N-specific antibody increase, the idiotype-specific 
increase did not reflect a departure from the percentage of idiotype expression. There 
is a  similarity in this observation to the findings of Reth et al.  (26)  who found that 
regulation by a  given anti-idiotype antibody need not be restricted to the expression 
of the corresponding idiotype but could extend to other idiotypes as well. There are 
other similar observations that have been reported earlier, and a  number of possible 
explanations  for these  results  have been  suggested.  In  some instances,  it  has  been 
suggested  that  antibodies  directed  to  two  individual  antigenic  determinants  may 
share idiotypes. That this may be the case in some systems was demonstrated by Bona 
and co-workers (27)  with anti-allotypic sera from a variety of mouse strains. This has 
also been observed with anti-idiotypes raised against rnonoclonal antibodies directed 
to distinct  determinants on influenza  virus  (28),  and  with  anti-idiotype directed  to 
antibodies  raised  to  synthetic  polypeptides  with  differing  determinant  specificities 
(29).  Whether or not this is the case with the Fd system remains to be established. At 
this time anti-Fd-I antiserum has not shown reactivity with any monoclonal antibodies 
isolated which have specificity for the C  epitope.  This, of course, does not  preclude 
the possibility of cross-reactive idiotypes on cells with specificity for the C  epitope. 
A second possibility by which the effect of anti-Fd-1 on the anti-C epitope response 
could  be explained  in  the  network  is  that  regulatory  idiotypes  may be present  on 
clones which secrete antibodies of differing specificities but which are recognized and/ 
or suppressed  by the  same set  of regulatory T  cells.  This  has  been  suggested  as  a 
mechanism to explain control and regulation of network responses to a  monoclonal 
levan-binding antibody  (A48  or Aba)  in  which  Ab3 and  Abl  share  a  cross-reactive 
idiotype, in that both are bound by Ab2 and Ab4 (30).  The model presented suggests 
the presence or absence of regulatory idiotypes in regulation of the expression of given 
idiotypes. More recently (31), it was shown that T  helper cells that were anti-idiotypic 
for antibody to phosphorylcholine  (PC)  were able to help  in  the anti-PC response, 
whether the hapten (PC) was conjugated to either T15 or M167  (indicating that the 
T  helper cells recognized a  shared idiotypic determinant  on these two idiotypically 
different myelorna proteins).  The possible regulatory function  of such a  recognition 
site was discussed in terms ofclonal dominance and in cyclical appearance ofidiotypic 
and anti-idiotypic cells during the immune response. 
Although  these  mechanisms  may  explain  the  regulatory  effects  that  anti-Fd-1 
antibodies  exert on the response of BI0.BR mice to both the N  and C  epitope, it is 
also possible that mechanisms outside the immunologic network may be responsible 
for the observed effect; i.e., the classical hapten-carrier effects. Previous studies on Fd 
have shown  that  there  are  only two  immunologically  reactive regions  present  and 
that these two epitopes are active at both the B and T  cell level (32).  Thus, in terms 
of hapten carrier interactions, it may be assumed that during the response to Fd, one 
epitope provides the help necessary to generate a response to the other. The idiotype- 
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for the N  epitope by definition. Because N  epitope binding T  cells may also provide 
the help or suppression  of the C-specific response,  it  is  possible  that  the  idiotype- 
positive cell affects the function of other N-binding T  helper cells that may or may 
not be idiotypically related. It is impossible at this time to define more precisely the 
nature of the cells involved in generating the increased help for the C epitope response, 
as treatment  of primed T  cells with anti-idiotype may preferentially eliminate one 
idiotype population  over another.  That  this  may be  the  case  is  borne out  by the 
observation  that  treatment  of whole spleen  cells  with  anti-idiotype plus  or minus 
complement  before  adoptive  transfer  still  results  in  a  proportionate  increase  in 
idiotype expression in treated mice, indicating that the idiotype-positive B cells were 
not eliminated by this treatment.  It was also observed that  treatment of mice with 
small amounts (10/~g) of the Fd-1 idiotype resulted in a significant increase in both 
N  and C  antibody (i.e.,  a  similar effect), so it may be suggested that  both idiotype- 
positive and  -negative cells  interact  in  the  same  regulatory circuit.  Recent  studies 
using the levan-binding myeloma protein A48 showed that  neonatal mice injected 
with 0.1-10 #g of the A48 monoclonal antibody and subsequently immunized with 
bacterial levan (BL) produced anti-BL antibody dominated by the A48 idiotype (33). 
The expansion  of this  clone was  found  to  be  attributable  to  the  stimulation  of a 
population of idiotype-negative T helper cells. These workers thus have demonstrated 
an idiotype-induced idiotype response mediated by idiotype-specific helper cells. The 
results presented here are essentially diametrically opposed to these observations, in 
that Fd-l-treated Fd-immunized animals, while demonstrating an overall increase in 
anti-Fd antibody, showed a  marked decrease in the expression of the Fd-1  idiotype 
(Table IV). It would thus be compatible to propose that the putative idiotype-specific 
anti-Fd-l-bearing  cells  (those affected by Fd-1),  rather  than  being helper cells,  in 
terms of interaction with Fd-l-bearing B cells, may represent cells that act as helpers 
in  the suppression  circuit  (already described)  which  is  dominated by suppressor T 
cells bearing the Fd-1 idiotype. 
A  possible  model  by  which  these  observations  can  be  explained  by  network 
interactions is shown in Fig. 5.  In this model, the B~  d+ cell represents the idiotype- 
bearing/antigen-binding B cell, which may be stimulated by traditional T helper cells 
with specificity for the C-epitope and acting via the hapten carrier effect (these are 
not shown). Because anti-Fd-1  has a stimulatory effect on B~  d+ expression indirectly 
through  T  cells,  it  is  necessary  to  introduce  a  second  T  cell  population  (the  a 
population), which bears the Fd-1 idiotype and is influenced by the presence of anti- 
Fd-1 because of its interaction with the T~  d+ regulatory cells (population b). It is this 
population also  (the T Id+)  that  could  function in  regulating  the help required to 
increase the production of C-epitope specific antibody. The N-binding T  helper cells 
under control of the T~  td+ regulatory cell (population c) may or may not be idiotype- 
positive. The  finding that  animals  receiving cells treated with  the  idiotype (Fd-1) 
exhibited similar effects in their response to Fd, as did those receiving anti-idiotype- 
treated cells, making it possible to suggest  that  the T Id+  and TN Icl+ regulatory cells 
affected  may  be  members  of the  same  circuit  and  that  interference with  either 
population with either idiotype or anti-idiotype disrupts the regulatory (suppressor) 
circuit.  This model has been kept simple,  and  we  do not  deny the possibility that 
there may be a  number of functionally distinct idiotypically linked T  cells (helpers, 298  IDIOTYPIC MARKERS ON  REGULATORY T  CELLS 
suppressors) that may be preferentially affected by the treatments (anti-Fd-1 or Fd-1) 
used here. 
Most of the work done using anti-idiotypic antisera directed to monoclonal anti- 
bodies specific for a given epitope has shown that this kind of perturbation results in 
either  an  enhanced  or  suppressed  response  to  that  epitope  and  specific  idiotype 
expression, depending on the way in which the experiments have been carried out. In 
the  experiments  discussed  here,  we  have  shown  that  the  anti-idiotypic  sera  act 
indirectly  via  T  cells,  but  that  they  do  not  appear  to  enhance  significantly  the 
expression of idiotype-positive B cells. What perhaps makes these experiments of some 
interest  in  network  studies  is  that  we  present  clear  evidence  that  those  idiotype- 
positive T cells affected bring about amplification of responses to the other apparently 
unrelated  epitope  on  the  Fd  molecule.  This  gives  evidence  for  the  existence  of 
conneetance  between  epitopicatly  unrelated  compartments  of the  immune  system 
mediated  through  idiotypic  as  well  as  antigen-bridging  interactions.  The  model 
proposed here, and for which the data presented give support, suggests connectance 
via idiotype-positive and -negative T  cells that regulate the response to both epitopes 
on the molecule through both idiotypic interactions and conventional hapten-carrier 
interactions.  Although this aspect of network has been predicted, to our knowledge, 
these observations constitute the first direct evidence for such an occurrence. Ongoing 
research in this laboratory is being directed to more definitive analysis of the idiotype- 
positive and -negative T  cell populations involved in this regulatory circuit, both in 
terms of their phenotype and in terms of the mechanism of their interaction. 
Summary 
An anti-idiotypic antiserum was raised in rabbits to a monoclonal antibody (Fd-1) 
with specificity for one  (the  N  epitope)  of the  two antigenic epitopes  found on the 
ferredoxin  (Fd)  molecule.  The  anti-idiotypic  antiserum  (anti-Fd-1)  was  used  to 
demonstrate that the Fd-1 idiotype was expressed at significant levels  in most anti-Fd 
antisera raised in B 10.BR mice. Examination of antisera raised in other mouse strains 
demonstrated that expression of this idiotype mapped to the IgH gene complex and 
was found in the antisera of all mouse strains examined with the Ig-1  b allotype. When 
splenocytes from Fd-immune B10.BR  mice were  treated  with  anti-Fd-1  and  trans- 
ferred to irradiated syngeneic recipients, the adoptive secondary response was signif- 
icantly higher in animals receiving treated cells as opposed to control animals, which 
received normal rabbit serum-treated cells.  This response produced a net increase in 
antibody to  both  determinants,  and  the  relative  amount  of Fd-1  idiotype was  not 
significantly altered.  Further studies with separated cell populations showed that the 
overall increase of anti-Fd antibody produced was attributable  to the effects of the 
anti-idiotypic serum on a  population(s)  of T  cells.  Treatment of mice with the Fd-1 
monoclonat antibody (which should react with anti-idiotypic cells)  had an analogous 
effect to that of the anti-idiotype, in that mice so treated produced higher concentra- 
tions of anti-Fd antibodies when they were immunized and these antibodies exhibited 
net increases to both determinants.  A model is presented to explain these results. 
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